1st Quarter - Amendment
THORN RUN PARTNERS for BIOGEN
Firm
Client
Income
$50,000
Expenses
—
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report | Apr 20, 2020 | $40,000 | Replaced |
| 1st Quarter - Amendment (this page) | Apr 20, 2020 | $50,000 | Yes |
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Legislation that would alter payment policies under Medicare Part B for drugs and biologics. Issues pertaining to Medicare Part D. International Pricing Indexing proposals.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BEAU SCHUYLER | Legislative Director - Cong. Tanner, Legislative Director - Cong. McIntyre |
Health Issues HCR
Biosimilar policies legislation. Legislation regarding drug importation. H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BEAU SCHUYLER | Legislative Director - Cong. Tanner, Legislative Director - Cong. McIntyre |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.